We are live on ! Find out more
JP

John Paulson Paulson & Co

AUM $2.58B
1-Year Est. Return 68.51%
 

John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.

This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$4.35B
AUM Growth
+$502M
Cap. Flow
+$102M
Cap. Flow %
2.34%
Top 10 Hldgs %
74.92%
Holding
39
New
3
Increased
5
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$178M
2
PPTA
Perpetua Resources
PPTA
+$144M
3
OXY icon
Occidental Petroleum
OXY
+$45.4M
4
TIMB icon
TIM SA
TIMB
+$35.5M
5
MIK
Michaels Stores, Inc
MIK
+$35.3M

Top Sells

Rank Stock Value
1
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$181M
2
TAK icon
Takeda Pharmaceutical
TAK
+$118M
3
PARA
Paramount Global Class B
PARA
+$58.5M
4
AEL
American Equity Investment Life Holding Company
AEL
+$27.7M
5
THRY icon
Thryv Holdings
THRY
+$8.31M

Sector Composition

Rank Sector Weight
1 Healthcare 51.7%
2 Materials 18.63%
3 Financials 9.36%
4 Communication Services 4.03%
5 Energy 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
1
Bausch Health
BHC
$2.41B
$820M 18.83%
25,839,035
– –
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$736M 16.89%
7,991,440
– –
AAMI
3
Acadian Asset Management
AAMI
$3.28B
$408M 9.36%
20,000,552
– –
GLD icon
4
SPDR Gold Trust
GLD
$152B
$303M 6.96%
1,894,252
– –
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$214M 4.92%
1,400,000
+1,150,000
+460% +$178M
NG icon
6
NovaGold Resources
NG
$3.83B
$195M 4.47%
22,226,300
– –
VTRS icon
7
Viatris
VTRS
$18.7B
$160M 3.68%
11,478,260
– –
PPTA
8
Perpetua Resources
PPTA
$3.21B
$160M 3.67%
+20,935,732
New +$144M
ENDP
9
DELISTED
Endo International plc
ENDP
$136M 3.12%
18,327,012
– –
AU icon
10
AngloGold Ashanti
AU
$61.3B
$131M 3.01%
5,974,331
– –
DISH
11
DELISTED
DISH Network Corp.
DISH
$131M 3.01%
3,620,750
– –
PCRX icon
12
Pacira BioSciences
PCRX
$983M
$99.1M 2.28%
1,413,854
– –
TAK icon
13
Takeda Pharmaceutical
TAK
$58.1B
$86.3M 1.98%
4,727,415
-6,568,431
-58% -$118M
OXY icon
14
Occidental Petroleum
OXY
$61.3B
$79.9M 1.83%
3,000,000
+1,815,000
+153% +$45.4M
B
15
Barrick Mining
B
$78.3B
$70.2M 1.61%
3,546,771
-1
-0% -$22
THM
16
International Tower Hill Mines
THM
$735M
$66.3M 1.52%
61,930,724
– –
THRY icon
17
Thryv Holdings
THRY
$92.4M
$65.6M 1.51%
2,805,533
-410,904
-13% -$8.31M
KL
18
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$63.9M 1.47%
1,502,853
– –
XOM icon
19
ExxonMobil
XOM
$679B
$55.8M 1.28%
1,000,000
+435,000
+77% +$22.8M
TIMB icon
20
TIM SA
TIMB
$8.52B
$44.3M 1.02%
3,900,000
+2,898,795
+290% +$35.5M
MIK
21
DELISTED
Michaels Stores, Inc
MIK
$43.9M 1.01%
+2,000,000
New +$35.3M
TLND
22
DELISTED
Talend S.A. American Depositary Shares
TLND
$41.4M 0.95%
+650,000
New +$33.8M
RP
23
DELISTED
RealPage, Inc.
RP
$34.9M 0.8%
400,000
– –
TMQ
24
Trilogy Metals
TMQ
$684M
$30.7M 0.7%
14,326,996
– –
XLE icon
25
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
$29.2M 0.67%
1,190,000
– –
1
2

Similar funds

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.57B AUM 21.7% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
CTA
Chesley Taft & Associates Chicago, Illinois $2.57B AUM 22.93% 1-Year Est. Return
VWM
Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

John Paulson's Q1 2021 Portfolio in Review

As of Q1 2021, John Paulson held 39 positions worth $4.35B, up 13% from $3.85B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

John Paulson's Q1 2021 filing shows 3 new, 5 increased, 3 reduced and 3 closed positions. Its largest new stake was Perpetua Resources: 20,935,732 shares worth $160M. The largest sale was Discovery, Inc. Series C Common Stock, an estimated $181M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Materials and Financials.

  • John Paulson's largest Q1 2021 buy was Perpetua Resources: 20,935,732 shares worth $160M.
  • John Paulson added most to Alexion Pharmaceuticals in Q1 2021, an estimated $178M increase.
  • John Paulson's biggest Q1 2021 reduction was Takeda Pharmaceutical, cutting an estimated $118M.
  • John Paulson fully exited Discovery, Inc. Series C Common Stock in Q1 2021, selling an estimated $181M.
  • John Paulson's ten largest holdings make up 75% of its $4.35B portfolio in Q1 2021.
  • John Paulson opened 3 new positions and closed 3 in Q1 2021.
  • John Paulson's portfolio value rose 13% quarter-over-quarter to $4.35B.

Based on Paulson & Co's 13F filing for Q1 2021, filed 17 May 2021.